A dozen global pharmaceutical companies have joined effort to accelerate critical therapies to citizens of the worldBURLINGAME, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) Accumulus Synergy, a non-profit
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, today announced Merck, known as MSD outside the United States and Canada, has joined Accumulus Synergy as a sponsor .
BURLINGAME, Calif., May 12, 2022 (GLOBE NEWSWIRE) Accumulus Synergy, a nonprofit organization working to develop an information and data exchange platform aimed at transforming how drug innovators and